日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Tyrosine-protein phosphatase 2 (ptp-2), partial CSB-YP338899CXY
CSB-EP338899CXY
CSB-BP338899CXY
CSB-MP338899CXY
CSB-EP338899CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Styela plicata Tyrosine-protein phosphatase 8 (STY-8) CSB-YP338900SQW
CSB-EP338900SQW
CSB-BP338900SQW
CSB-MP338900SQW
CSB-EP338900SQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Styela plicata Tyrosine-protein phosphatase 13 (STY-13) CSB-YP338901SQW
CSB-EP338901SQW
CSB-BP338901SQW
CSB-MP338901SQW
CSB-EP338901SQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Styela plicata Tyrosine-protein phosphatase 18 (STY-18) CSB-YP338902SQW
CSB-EP338902SQW
CSB-BP338902SQW
CSB-MP338902SQW
CSB-EP338902SQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Styela plicata Tyrosine-protein phosphatase 27 (STY-27) CSB-YP338903SQW
CSB-EP338903SQW
CSB-BP338903SQW
CSB-MP338903SQW
CSB-EP338903SQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Galdieria sulphuraria Photosystem II D2 protein (psbD), partial CSB-YP338904GAD1
CSB-EP338904GAD1
CSB-BP338904GAD1
CSB-MP338904GAD1
CSB-EP338904GAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Angiopteris lygodiifolia Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338905AKG
CSB-EP338905AKG
CSB-BP338905AKG
CSB-MP338905AKG
CSB-EP338905AKG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Small basic protein (sbp), partial CSB-YP338906BRJ1
CSB-EP338906BRJ1
CSB-BP338906BRJ1
CSB-MP338906BRJ1
CSB-EP338906BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human herpesvirus 2 Transcriptional regulator ICP27 (UL54), partial CSB-YP338907HJX
CSB-EP338907HJX
CSB-BP338907HJX
CSB-MP338907HJX
CSB-EP338907HJX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human herpesvirus 2 Tegument protein UL55 (UL55) CSB-YP338908HJX
CSB-EP338908HJX
CSB-BP338908HJX
CSB-MP338908HJX
CSB-EP338908HJX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Absidia glauca Elongation factor 1-alpha (TEF-1) CSB-YP338909AAD
CSB-EP338909AAD
CSB-BP338909AAD
CSB-MP338909AAD
CSB-EP338909AAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Isocitrate lyase (acu-3), partial CSB-YP338910NHA
CSB-EP338910NHA
CSB-BP338910NHA
CSB-MP338910NHA
CSB-EP338910NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli UPF0755 protein yceG (yceG) CSB-YP338911ENV
CSB-EP338911ENV
CSB-BP338911ENV
CSB-MP338911ENV
CSB-EP338911ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Nitrogen assimilation transcription factor nirA (nirA), partial CSB-YP338912EKF
CSB-EP338912EKF
CSB-BP338912EKF
CSB-MP338912EKF
CSB-EP338912EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acer saccharum Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338913AAU
CSB-EP338913AAU
CSB-BP338913AAU
CSB-MP338913AAU
CSB-EP338913AAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Casuarina equisetifolia Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338914CEO
CSB-EP338914CEO
CSB-BP338914CEO
CSB-MP338914CEO
CSB-EP338914CEO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338915DAJ
CSB-EP338915DAJ
CSB-BP338915DAJ
CSB-MP338915DAJ
CSB-EP338915DAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosera burmannii Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338916DFE
CSB-EP338916DFE
CSB-BP338916DFE
CSB-MP338916DFE
CSB-EP338916DFE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophyllum lusitanicum Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338917DHC
CSB-EP338917DHC
CSB-BP338917DHC
CSB-MP338917DHC
CSB-EP338917DHC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eucommia ulmoides Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP338918EHN
CSB-EP338918EHN
CSB-BP338918EHN
CSB-MP338918EHN
CSB-EP338918EHN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×